Cartesian Therapeutics is developing non-permanent cell therapies that can be used soon after diagnosis and address a wide range of diseases beyond cancer. The biotech’s approach to cell engineering relies upon RNA rather than DNA to effect changes within the cells. The benefit, Cartesian President and CEO Murat Kalayoglu, M.D., Ph.D. told BioSpace, is that “our […]

Sutro Biopharma Inc. (NASDAQ: STRO) has announced that it will present preliminary data from its current dose-expansion cohort of the first phase STRO-002 study in ovarian cancer patients at a KPL virtual event. Phase 1 dose expansion group comprises ovarian cancer patients  The first phase dose-expansion cohort comprises advanced ovarian cancer patients with progressing illness who […]

Post-operative cognitive decline (POCD) is a state in which new cognitive impairments arise in patients after a surgical procedure. It can occur in patients following surgeries to repair a hip fracture, coronary artery bypass, or other procedures. People who suffer from POCD can develop difficulty remembering things and performing daily tasks, and may possibly end […]